These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10898572)
41. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Meares CF; McCall MJ; Reardan DT; Goodwin DA; Diamanti CI; McTigue M Anal Biochem; 1984 Oct; 142(1):68-78. PubMed ID: 6440451 [TBL] [Abstract][Full Text] [Related]
42. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction. Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373 [TBL] [Abstract][Full Text] [Related]
44. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development. Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459 [TBL] [Abstract][Full Text] [Related]
45. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates. Govindan SV; Michel RB; Griffiths GL; Goldenberg DM; Mattes MJ Nucl Med Biol; 2005 Jul; 32(5):513-9. PubMed ID: 15982582 [TBL] [Abstract][Full Text] [Related]
46. Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases. Chang MY; Seideman J; Sofou S Bioconjug Chem; 2008 Jun; 19(6):1274-82. PubMed ID: 18505278 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with Allen KJH; Jiao R; Malo ME; Dadachova E Cancer Biother Radiopharm; 2018 Oct; 33(8):349-355. PubMed ID: 30010404 [TBL] [Abstract][Full Text] [Related]
48. Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; model study to potential calix[4]arene-based Ac3+ chelators. Grote Gansey MH; de Haan AS; Bos ES; Verboom W; Reinhoudt DN Bioconjug Chem; 1999; 10(4):613-23. PubMed ID: 10411459 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics. Chong HS; Garmestani K; Ma D; Milenic DE; Overstreet T; Brechbiel MW J Med Chem; 2002 Aug; 45(16):3458-64. PubMed ID: 12139456 [TBL] [Abstract][Full Text] [Related]
50. Efficient multigram synthesis of the bifunctional chelating agent (S)-1-p-isothiocyanatobenzyl-diethylenetriaminepentaacetic acid [correction of diethylenetetraminepentaacetic acid]. Corson DT; Meares CF Bioconjug Chem; 2000; 11(2):292-9. PubMed ID: 10725108 [TBL] [Abstract][Full Text] [Related]
51. Synthesis of the first diethylenetriaminepentahydroxamic acid (DTPH) bifunctional chelating agent. Safavy A; Smith DC; Bazooband A; Buchsbaum DJ Bioconjug Chem; 2002; 13(2):327-32. PubMed ID: 11906271 [TBL] [Abstract][Full Text] [Related]
53. Targeted actinium-225 in vivo generators for therapy of ovarian cancer. Borchardt PE; Yuan RR; Miederer M; McDevitt MR; Scheinberg DA Cancer Res; 2003 Aug; 63(16):5084-90. PubMed ID: 12941838 [TBL] [Abstract][Full Text] [Related]
54. Synthesis of new bivalent peptides for applications in the Affinity Enhancement System. Morandeau L; Benoist E; Loussouarn A; Ouadi A; Lesaec P; Mougin M; Faivre-Chauvet A; Le Boterff J; Chatal JF; Barbet J; Gestin JF Bioconjug Chem; 2005; 16(1):184-93. PubMed ID: 15656590 [TBL] [Abstract][Full Text] [Related]
55. RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. Boros E; Ferreira CL; Yapp DT; Gill RK; Price EW; Adam MJ; Orvig C Nucl Med Biol; 2012 Aug; 39(6):785-94. PubMed ID: 22381779 [TBL] [Abstract][Full Text] [Related]
56. Efficient synthesis and evaluation of bimodal ligand NETA. Chong HS; Song HA; Birch N; Le T; Lim S; Ma X Bioorg Med Chem Lett; 2008 Jun; 18(11):3436-9. PubMed ID: 18445528 [TBL] [Abstract][Full Text] [Related]
57. A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Kukis DL; Diril H; Greiner DP; DeNardo SJ; DeNardo GL; Salako QA; Meares CF Cancer; 1994 Feb; 73(3 Suppl):779-86. PubMed ID: 8306260 [TBL] [Abstract][Full Text] [Related]
58. Computer-Assisted Design of Macrocyclic Chelators for Actinium-225 Radiotherapeutics. Morgenstern A; Lilley LM; Stein BW; Kozimor SA; Batista ER; Yang P Inorg Chem; 2021 Jan; 60(2):623-632. PubMed ID: 33213142 [TBL] [Abstract][Full Text] [Related]
59. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts. Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333 [TBL] [Abstract][Full Text] [Related]
60. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]